| Code | 3125D | ||||||||||
| MA number | 83/0392/19-S | ||||||||||
| Product Form: | tbl flm 80x5 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 13.01.2020 |
| PIL: |
PIL_TADALAFIL FMK 5 mg_tbl flm_05_2025.pdf
|
| SPC: |
SPC_TADALAFIL FMK 5 mg_tbl flm_05_2025.pdf
|
| Safety feature | Yes |
| Data update: | 21.06.2024 |
